Advaxis, Inc. Cures Late Form 10-Q Filing

NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Lm) vaccine company, announced today that the Company’s ticker symbol has been temporarily changed to ADXSE denoting untimely filing of the Company’s July 31, 2009 Third Quarter and Nine-Month Form 10-Q as required by the OTC Bulletin Board.

MORE ON THIS TOPIC